Ubs Group Ag Seelos Therapeutics, Inc. Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.16 - $1.64 $11 - $118	-72 Reduced 3.13%	2,226 $0
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $47 - $87	72 Added 3.23%	2,298 $2,000
Q1 2023 May 12, 2023	SELL	$0.59 - $1.04 $4,435 - $7,817	-7,517 Reduced 77.15%	2,226 $1,000
Q4 2022 Feb 08, 2023	SELL	$0.66 - $259.46 $9,135 - $3.59 Million	-13,842 Reduced 58.69%	9,743 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.65 - $278.68 $13,883 - $5.95 Million	21,359 Added 959.52%	23,585 $24,000
Q2 2022 Aug 10, 2022	SELL	$0.51 - $0.93 $753 - $1,373	-1,477 Reduced 39.89%	2,226 $2,000
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $33,463 - $68,121	-39,837 Reduced 91.5%	3,703 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $64,396 - $96,392	40,501 Added 1332.71%	43,540 $70,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $5,070 - $8,670	3,000 Added 7692.31%	3,039 $7,000
Q2 2021 Aug 13, 2021	SELL	$2.64 - $6.32 $22,672 - $54,276	-8,588 Reduced 99.55%	39 $0
Q1 2021 May 12, 2021	BUY	$1.35 - $4.99 $11,593 - $42,854	8,588 Added 22020.51%	8,627 $43,000
Q4 2020 Feb 11, 2021	BUY	$0.74 - $2.01 $1 - $4	2 Added 5.41%	39 $0
Q3 2020 Nov 12, 2020	SELL	$0.6 - $1.25 $2,184 - $4,551	-3,641 Reduced 98.99%	37 $0
Q2 2020 Jul 31, 2020	SELL	$0.42 - $1.51 $3,768 - $13,547	-8,972 Reduced 70.92%	3,678 $4,000
Q1 2020 May 01, 2020	BUY	$0.47 - $1.56 $5,945 - $19,732	12,649 Added 1264900.0%	12,650 $6,000
Q2 2019 Aug 14, 2019	SELL	$2.11 - $3.3 $2,008 - $3,141	-952 Reduced 99.9%	1 $0
Q1 2019 May 14, 2019	BUY	$1.45 - $8.1 $1,381 - $7,719	953 New	953 $3,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $341M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.